Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2005-11-08
2005-11-08
Smith, Ruth S. (Department: 3737)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C324S307000, C324S309000, C424S009300
Reexamination Certificate
active
06963769
ABSTRACT:
A method for obtaining an image by MRI, comprising: administering at least one contrast agent to a subject in amounts effective to perform CEDST MRI analysis; and performing CEDST MRI analysis to produce an image of the subject. A number of different contast agents can be used to practice the present method including, without limitation, sugars, animo acids, nitrogen-containing heterocycles, purines and pyrimidines, nucleosides; imidazole and derivatives thereof, imino acids, barbituric acid and analogs thereof, and miscellaneous materials, such as guanidine hydantoin, parabanic acid, and biologically active salts thereof.
REFERENCES:
patent: 5050609 (1991-09-01), Balaban et al.
patent: 5639906 (1997-06-01), London et al.
patent: 6023634 (2000-02-01), Hanawa et al.
patent: 2002/0127182 (2002-09-01), Sherry et al.
patent: 0 095 124 (1983-11-01), None
patent: 0 122 000 (1984-10-01), None
patent: 0 368 429 (1990-05-01), None
patent: 1331012 (2003-07-01), None
patent: WO 95/17910 (1995-07-01), None
patent: WO 98/39664 (1998-09-01), None
patent: WO 99/55670 (1999-11-01), None
Database WPI, Section Ch, Week 200017, Derwent Publications Ltd., London, GB; AN 2000-195204, XP002161319 & WO 00 06207 A (Nippon Mediphysics Co. Ltd.), Feb. 10, 2000 abstract.
Ågren, “Low Brain Uptake of L-[11C]5-hydroxytryphan in Major Depression: A Positron Emission Tomography Study on Patients and Healthy Volunteers,”Acta Psychiatrica Scandinavica 83:449-455 (1991).
Ågren et al., “PET Studies With L-[11C]5-HTP and L-[11C]DOPA in Brains of Healthy Volunteers and Patients with Major Depression,”Clin. Neuropharm. 15:235A-236A (1992).
Aime et al., “A New Class of Contrast Agents for Magnetic Resonance Imaging Based on Selective Reduction of Water-T2 by Chemical Exchange,”Investigative Radiology 23:S267-S270 (1988).
Balaban et al., “Magnetization Transfer Contrast in Magnetic Resonance Imaging,”Magn. Reson. Quarterly 8:116-137 (1992).
Blamire et al., “Measurement of Myocardial pH by Saturation Transfer in Man, ”Medical Research Society Clinical Science 90:13P-14P (1996).
Bo et al., “Neuropharmacological Profile of Ketanserin,”Il Farmaco—Ed. Sc. 42:91-99 (1987).
Casali et al., “Evaluation of Gd-DOTA-Labeled Dextran Polymer as an Intravascular MR Contrast Agent for Myocardinal Perfusion,”Acad. Radiol. 5:S214-S218 (1998).
Filler, “Axonal Transport and MR Imaging: Prospects for Contrast Agent Development,”JMRI 4:259-267 (1994).
Foye et al., “Antiradiation Compounds XIX: Metal-Binding Abilities of Thioureas,”J. Pharm. Sci. 73:1284-1286 (1984).
Franken et al., “The Structure of Barbituric Acid and Its 5,5-Diethyl Derivative as Revealed by15N Nuclear Magnetic Resonance Techniques,”Tetrahedron 47:7593-7608 (1991).
Gochberg et al., “The Role of Specific Side Groups and pH in Magnetization Transfer in Polymers,”J. Magn. Reson. 131:191-198 (1998).
Goffeney et al., “Detection of Cationic-Polymer-Based Gene Delivery Systems Without Paramagnetic Metals,”Proc. Intl. Soc. Mag. Reson. Med. 9:871 (2001).
Govindaraju et al., “Effects of Brain Membranes on1H Nuclear Magnetic Resonance Signal Intensity of Ethanol In Vitro,”Alcohol&Alcoholism 32:671-681 (1997).
Guivel-Scharen et al., “Detection of Proton Chemical Exchange Between Metabolites and Water in Biological Tissues,”J. Magn. Reson. 133:36-45 (1998).
Hsieh et al., “31P Imaging of in Vivo Creatine Kinase Reaction Rates,”J. Magn. Reson. 74:574-579 (1987).
Kajander et al., “Determination of Saturation Transfer Parameters of Human Tissues In Vivo,”Magn. Imag. 14:413-417 (1996).
McFarland et al., “Chemical Exchange Magnetic Resonance Imaging (Chemi),”Magn. Reson. Imag. 6:507-515 (1988).
Meyerhoff et al., “Evidence of Multiple Ethanol Pools in the Brain: An in Vivo Proton Magnetization Transfer Study,”Alcoholism Clin. Exp. Res. 20:1283-1288 (1996).
Ohtani et al. “A Case of Malignant Hyperplasia During Anesthesia (Japanese),”Hiroshima J. Anesth. 7:19-26 (1971). (English abstract and article in Japanese.).
Pekar et al., “Perfusion Imaging with Compensation for Asymmetric Magnetization Transfer Effects,”MRM 35:70-79 (1996).
Prankerd et al., “Physico-Chemical Properties of Barbituric Acid Derivatives Part I. Solubility-Temperature Dependence for 5,5-Disubstituted Barbituric Acids in Aqueous Solutions,”International J. Pharm. 62:37-52 (1990).
Schupfner et al., “Temperature-Dependent ESR Studies of Radical Pairs in Single Crystals of Barbituric Acid,”Z. Naturforsch 44:849-856 (1989).
Taylor et al., “Fluorinate α-Methylamino Acids as19F NMR Indicators of Intracelluar pH,”Biophys. J. 43:261-267 (1983).
Thomas, “Magnetization Transfer in Magnetic Resonance Imaging,”Radiologic Tech. 67:297-306 (1996).
Ugurbil, “Magnetization-Transfer Measurements of Individual Rate Constants in the Presence of Multiple Reactions,”J. Magn. Reson. 64:207-219 (1985).
van Zijl et al., “The Use of Starburst Dendrimers as pH Contrast Agents,”Proc. Intl. Soc. Mag. Reson. Med. 9:878 (2001).
Ward et al., “Determination of pH Using Water Protons and Chemical Exchange Dependent Saturation Transfer (CEST),”Magn. Reson. Med. 44:799-802 (2000).
Ward et al., “A New Class of Contrast Agents for MRI Based on Proton Chemical Exchange Dependent Saturation Transfer (CEST),”J. Magn. Reson. 143:79-87 (2000).
Wolff et al., “Magnetization Transfer Contrast (MTC) and Tissue Water Proton Relaxation in Vivo,”Magn. Reson. Med. 10:135-144 (1989).
Wolff et al., “NMR Imaging of Labile Proton Exchange,”J. Magn. Reson. 86:164-169 (1990).
Zhang et al., “A Novel pH-Sensitive MRI Contrast Agent,”Angew. Chem. Int. Ed. 38:3192-3194 (1999).
Budavari et al., Merck Index, CD-ROM XP002176801, Merch & Co., Inc., Whitehouse Station, New Jersey, Monograph No. 3849, 1997.
Aletras Anthony H.
Balaban Robert S.
Ward Kathleen M.
Klarquist & Sparkman, LLP
Smith Ruth S.
The United States of America as represented by the Secretary of
LandOfFree
Method for enhancing contrast produced by MRI does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for enhancing contrast produced by MRI, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing contrast produced by MRI will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3503455